These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3169115)

  • 1. Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients.
    Sultan E; Richard C; Pezzano M; Auzepy P; Singlas E
    Eur J Clin Pharmacol; 1988; 34(6):637-43. PubMed ID: 3169115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of pefloxacin and amikacin administered simultaneously to patients undergoing resuscitation.
    Sultan E; Singlas E; Richard C; Auzepy P
    Chemioterapia; 1987 Jun; 6(2 Suppl):305-6. PubMed ID: 3509424
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
    Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of pefloxacin in goats after intravenous or oral administration.
    Malik JK; Rao GS; Ramesh S; Muruganandan S; Tripathi HC; Shukla DC
    Vet Res Commun; 2002 Feb; 26(2):141-9. PubMed ID: 11922483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pharmacokinetic study of pefloxacin in spontaneous ascitic fluid infections].
    Ducroix JP; Hary L; Andrejak M; Smail A; Tondriaux A; Eb F; Baillet J
    Therapie; 1990; 45(6):461-5. PubMed ID: 2080483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery.
    Gascón AR; Campo E; Olea E; Hernández RM; Calvo B; Errasti J; Pedraz JL
    Biopharm Drug Dispos; 2002 Oct; 23(7):293-300. PubMed ID: 12355580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nikolaidis P; Walker SE; Dombros N; Tourkantonis A; Paton TW; Oreopoulos DG
    Perit Dial Int; 1991; 11(1):59-63. PubMed ID: 2049424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state levels of pefloxacin and its metabolites in patients with severe renal impairment.
    Jungers P; Ganeval D; Hannedouche T; Prieur B; Montay G
    Eur J Clin Pharmacol; 1987; 33(5):463-7. PubMed ID: 3480804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens.
    Pant S; Rao GS; Sastry KV; Tripathi HC; Jagmohan ; Malik JK
    Br Poult Sci; 2005 Oct; 46(5):615-20. PubMed ID: 16359117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers.
    Petitjean O; Pangon B; Brion N; Tod M; Chaplain C; Le Gros V; Louchahi K; Allouch P
    Antimicrob Agents Chemother; 1993 Apr; 37(4):737-40. PubMed ID: 8494368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
    De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; De Schepper PJ
    J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of rifampin on the pharmacokinetics of pefloxacin.
    Humbert G; Brumpt I; Montay G; Le Liboux A; Frydman A; Borsa-Lebas F; Moore N
    Clin Pharmacol Ther; 1991 Dec; 50(6):682-7. PubMed ID: 1752112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and dosage regimens of amikacin in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Favereau JP; Gay R
    Int J Biomed Comput; 1994 Jun; 36(1-2):135-7. PubMed ID: 7927853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition kinetics and urinary excretion of pefloxacin after intravenous injection in crossbred calves.
    Srivastava AK; Dumka VK; Deol SS
    Vet Res Commun; 2000 Apr; 24(3):189-96. PubMed ID: 10836277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of pefloxacin into gynaecological tissues.
    Bouvet O; Bressolle F; Courtieu C; Galtier M
    J Antimicrob Chemother; 1992 May; 29(5):579-87. PubMed ID: 1624396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy: a way to limit emergence of resistance?
    Michéa-Hamzehpour M; Pechère JC; Marchou B; Auckenthaler R
    Am J Med; 1986 Jun; 80(6B):138-42. PubMed ID: 3088999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diffusion of pefloxacin in the aqueous humor and crystalline lens after repeated oral administration in man].
    Salvanet-Bouccara A; Montay G; Fisch A; Forestier F; Meziane D; Lafaix C; Prieur MB
    J Fr Ophtalmol; 1991; 14(4):260-4. PubMed ID: 1955654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.
    Dow J; Chazal J; Frydman AM; Janny P; Woehrle R; Djebbar F; Gaillot J
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():81-7. PubMed ID: 3458700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.